Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by tickle1ston May 08, 2011 10:47pm

342 Views

Post# 18547017

Clinical Trials

The most recent NR adds this person to the Sirona brain trust:

Biography of Dr. Stuart Maddin
Dr. Stuart Maddin isClinical Professor Emeritus at the Department of Dermatology and SkinScience of Dermatology (Active), Faculty of Medicine, University ofBritish Columbia, where he is the Director of the Clinical Trials Unit.

I think we're going to have some news soon.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?